LambotteO, BoufassaF, MadecY, et al.HIV controllers: A homogeneous group of HIV-1—Infected patients with spontaneous control of viral replication. Clin Infect Dis, 2005; 41(7):1053–1056; doi: 10.1086/433188.
2.
Avettand-FènoëlV, HocquelouxL, GhosnJ, et al.Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications. Clin Microbiol Rev, 2016; 29(4):859; doi: 10.1128/CMR.00015-16.
3.
WoldemeskelBA, KwaaAK, BlanksonJN. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies. eBioMedicine, 2020; 62:103118; doi: 10.1016/j.ebiom.2020.103118.
4.
HughesK, ChangJ, StadtlerH, et al.HIV-1 infection of the kidney: Mechanisms and implications. AIDS Lond Engl, 2021; 35(3):359–367; doi: 10.1097/QAD.0000000000002753.
5.
BakerEJ, HughesK, TraviesoT, et al.Establishment, persistence, and reactivation of latent HIV-1 infection in renal epithelial cells. J Virol, 2022; 96(14):e00624-22; doi: 10.1128/jvi.00624-22.
6.
RosenbergAZ, NaickerS, WinklerCA, et al.HIV-associated nephropathies: Epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol, 2015; 11(3):150–160; doi: 10.1038/nrneph.2015.9.
7.
LaurenceJ, ElhadadS, GostynskaS, et al.HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: Role of platelet-derived TGF-β1 and intervention via antioxidant pathways. AIDS, 2020; 34(7):989–1000; doi: 10.1097/QAD.0000000000002516.
8.
Avettand-FènoëlV, ChaixML, BlancheS, et al.LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01). J Med Virol, 2009; 81(2):217–223; doi: 10.1002/jmv.21390.
9.
CanaudG, Dejucq-RainsfordN, Avettand-FenoëlV, et al.The kidney as a reservoir for HIV-1 after renal transplantation. J Am Soc Nephrol, 2014; 25(2):407–419; doi: 10.1681/ASN.2013050564.
10.
NoëlN, Sáez-CiriónA, Avettand-FenoelV, et al.HIV controllers: To treat or not to treat? Is that the right question?. Lancet HIV, 2019; 6(12):e878‑84; doi: 10.1016/S2352-3018(19)30264-4.
11.
BohmartA, BurnsG. Renal disease in an urban HIV population in the era prior and following the introduction of highly active antiretroviral therapy. J Natl Med Assoc, 2011; 103(6):513–517; doi: 10.1016/s0027-9684(15)30366-7.
12.
AbrahamAG, AlthoffKN, JingY, et al.End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis, 2015; 60(6):941–949; doi: 10.1093/cid/ciu919.
